Breast cancer survivors may also be taking other medicines, including hormonal therapies, which could potentially interact with metabolic treatments
Applicable Procedure Codes: 0582T, 0655T, 0714T, 0738T, 0739T, 0867T, 37243, 51721, 52441, 52442, 52443, 52597, 53850, 53852, 53854, 53855, 53865, 53866, 55873, 55877, 55881, 55882
The highest discontinuation rate was 8%, occurring in the highest dose group
Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term
Some Indian brands are approved for both, others for one indication only
Adverse events were primarily gastrointestinal, with nausea significantly more frequently in the GLP-1RAs group (OR = 2.01, 95% CI 1.24 to 3.27)